These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 19404209

  • 1. Gastrointestinal stromal tumor complicated by Streptococcus milleri bacteremia and liver abscess.
    Kwon Y, Dang ND, Elmunzer BJ.
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):824-6. PubMed ID: 19404209
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M, Sobin LH, Lasota J.
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
    Liegl B, Hornick JL, Corless CL, Fletcher CD.
    Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M, Wang ZF, Lasota J.
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinicopathological features of gastric stromal tumors.
    Nishida T, Nakamura J, Taniguchi M, Hirota S, Ito T, Kitamura Y, Matsuda H.
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S, Chen LR, Wang HJ, Chen SZ.
    Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
    Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y.
    Cancer Res; 1999 Sep 01; 59(17):4297-300. PubMed ID: 10485475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
    Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri GD, Fletcher CD, Fletcher JA.
    Cancer Res; 2001 Nov 15; 61(22):8118-21. PubMed ID: 11719439
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.